Tomuzotuximab Uses, Dosage, Side Effects and more
Tomuzotuximab is under investigation in clinical trial NCT02052960 (CetuGEX™ in Comparison to Cetuximab for the Treatment of Patients With Head and Neck Cancer).
| Trade Name | Tomuzotuximab |
| Generic | Tomuzotuximab |
| Tomuzotuximab Other Names | Tomuzotuximab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
